Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 5/20 | 1.00 |
| ▸ | KMT2A | Q03164 | 5/20 | 1.00 |
| ▸ | KDM4E | B2RXH2 | 4/20 | 1.00 |
| ▸ | ALOX15 | P16050 | 3/20 | 1.00 |
| ▸ | MAPT | P10636 | 3/20 | 1.00 |
| ▸ | FBP1 | P09467 | 2/20 | 1.00 |
| ▸ | SLCO2B1 | O94956 | 2/20 | 1.00 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 1.00 |
| ▸ | CYP19A1 | P11511 | 2/20 | 1.00 |
| ▸ | HPGD | P15428 | 2/20 | 1.00 |
| ▸ | APEX1 | P27695 | 2/20 | 1.00 |
| ▸ | DAPK1 | P53355 | 2/20 | 1.00 |
| ▸ | GLA | P06280 | 1/20 | 1.00 |
| ▸ | HSPD1 | P10809 | 1/20 | 1.00 |
| ▸ | RAD52 | P43351 | 1/20 | 1.00 |
| ▸ | HSPE1 | P61604 | 1/20 | 1.00 |
| ▸ | TST | Q16762 | 1/20 | 1.00 |
| ▸ | BCL9 | O00512 | 7/20 | 0.73 |
| ▸ | CTNNB1 | P35222 | 7/20 | 0.73 |
| ▸ | CDK1 | P06493 | 3/20 | 0.67 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Gossypetin SCHEMBL157033 | 1.00 | MEN1 (1.00) | MEN1KMT2AKDM4EALOX15MAPT | |
| Gossypetin SCHEMBL29929428 | 1.00 | MEN1 (1.00) | MEN1KMT2AKDM4EALOX15MAPT | |
| Gossypetin SCHEMBL16782915 | 0.98 | MEN1 (0.97) | MEN1KMT2AKDM4EALOX15MAPT | |
| SCHEMBL30190288 | 0.87 | MEN1 (0.77) | MEN1KMT2AKDM4EALOX15MAPT | |
| SCHEMBL12640014 | 0.87 | MEN1 (0.77) | MEN1KMT2AKDM4EALOX15MAPT | |
| SCHEMBL20200773 | 0.87 | MEN1 (0.77) | MEN1KMT2AKDM4EALOX15MAPT | |
| SCHEMBL13857095 | 0.87 | MEN1 (0.77) | MEN1KMT2AKDM4EALOX15MAPT | |
| SCHEMBL29575800 | 0.87 | MEN1 (0.77) | MEN1KMT2AKDM4EALOX15MAPT | |
| Herbacetin SCHEMBL31442430 | 0.86 | FBP1 (1.00) | MEN1KMT2AKDM4EALOX15MAPT | |
| Herbacetin SCHEMBL872691 | 0.86 | FBP1 (1.00) | MEN1KMT2AKDM4EALOX15MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250364084-A1 | METHODS FOR USING A MACHINE LEARNING ALGORITHM FOR OMIC ANALYSIS | SEER INC (US) | 2025-11-27 | — | — | US | disclosed |
| US-20250339399-A1 | SUPRAMOLECULAR SELF-ASSEMBLY SYSTEM | BEIJING CREATRON INSTITUTE OF PHARMACEUTICAL RES CO LTD (CN) | 2025-11-06 | — | — | US | disclosed |
| WO-2025038482-A2 | USE OF FISETIN FOR REDUCING THE INCIDENCE OF ATRIAL FIBRILLATION | RHODE ISLAND HOSPITAL (US) | 2025-02-20 | — | — | WO | disclosed |
| US-20240377411-A1 | METHODS FOR DIAGNOSING AN AUTISTIC SPECTRUM DISORDER | QATAR UNIVERSITY (QA) | 2024-11-14 | — | — | US | disclosed |
| CN-118488954-A | Pyrrolo [2,1-F ] [1,2,4] triazine derivatives as DYRK1A inhibitors | 拜斯丽治疗有限公司 | 2024-08-13 | — | — | CN | disclosed |
| US-12044684-B2 | Methods for diagnosing an autistic spectrum disorder | QATAR UNIVERSITY (QA) | 2024-07-23 | — | — | US | disclosed |
| CN-117982428-A | Carrier-free co-assembled nanoparticle as well as preparation method and application thereof | 沈阳药科大学 | 2024-05-07 | — | — | CN | disclosed |
| CN-117883465-A | Combination medicine for nerve injury diseases and p38MAPK pathway inhibitor | 南京中医药大学 | 2024-04-16 | — | — | CN | disclosed |
| WO-2024040189-A1 | METHODS FOR USING A MACHINE LEARNING ALGORITHM FOR OMIC ANALYSIS | SEER, INC. (US) | 2024-02-22 | — | — | WO | disclosed |
| CN-117398465-A | Application of TAB2 protein as rabies treatment target | 吉林大学 | 2024-01-16 | — | — | CN | disclosed |
| CN-117202924-A | Therapeutic regimens and methods for lowering blood glucose and/or body weight using GLP-1R and GCGR balance agonists | 斯皮特弗尔制药有限责任公司 | 2023-12-08 | — | — | CN | disclosed |
| CN-114957362-B | Method for separating anti-inflammatory active ingredients of coreopsis tinctoria | 中国科学院西北高原生物研究所 | 2023-11-10 | — | — | CN | disclosed |
| WO-2023127826-A1 | ELECTROLYTIC CAPACITOR AND LIQUID COMPONENT FOR ELECTROLYTIC CAPACITOR | パナソニックＩＰマネジメント株式会社 | 2023-07-06 | — | — | WO | disclosed |
| WO-2023021082-A1 | COMPOSITION | GIVAUDAN SA (CH) | 2023-02-23 | — | — | WO | disclosed |
| US-20220304974-A1 | COMPOSITION COMPRISING GOSSYPETIN FOR PREVENTION OR TREATMENT OF NEURODEGENERATIVE DISEASE | NOVMETAHEALTH CO.,LTD. (KR) | 2022-09-29 | — | — | US | disclosed |
| EP-3970716-A1 | COMPOSITION COMPRISING GOSSYPETIN FOR PREVENTION OR TREATMENT OF NEURODEGENERATIVE DISEASE | Novmetahealth Co., Ltd. (KR) | 2022-03-23 | — | — | EP | disclosed |
| CN-114126607-A | Composition comprising gossypetin for preventing or treating neurodegenerative diseases | 诺代谢健康 | 2022-03-01 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220304974-A1 | COMPOSITION COMPRISING GOSSYPETIN FOR PREVENTION OR TREATMENT OF NEURODEGENERATIVE DISEASE | HTT, GRN, SNCA | MEN1 1130/4885KMT2A 649/4885KDM4E 1427/4885 |
| US-20250339399-A1 | SUPRAMOLECULAR SELF-ASSEMBLY SYSTEM | S100A8, TP53, AQP1 | MEN1 312/4885KMT2A 4248/4885KDM4E 4766/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.